2039-54-5

Basic information

• Product Name: m-methoxyphenethylamine hydrochloride
• Synonyms: m-methoxyphenethylamine hydrochloride;3-Methoxyphenethylamine hydrochloride;3-METHOXYPHENYLETHYLAMINE HCL;2-(3-Methoxyphenyl)ethanaMine hydrochloride
• CAS NO: 2039-54-5
• Molecular Formula: C₉H₁₃NO*ClH
• Molecular Weight: 187.66656
• EINECS: 218-015-8
• Mol File: 2039-54-5.mol
• Article Data: 3

Chemical Properties

• Boiling Point: 262.7°Cat760mmHg
• Flash Point: 104.9°C
• Appearance: /
• Density: g/cm³
• Vapor Pressure: 0.0108mmHg at 25°C
• CAS DataBase Reference: m-methoxyphenethylamine hydrochloride(CAS DataBase Reference)
• NIST Chemistry Reference: m-methoxyphenethylamine hydrochloride(2039-54-5)
• EPA Substance Registry System: m-methoxyphenethylamine hydrochloride(2039-54-5)

Safety Data

• Hazardous Substances Data: 2039-54-5(Hazardous Substances Data)

Usage

General Description

M-methoxyphenethylamine hydrochloride is a chemical compound that belongs to the family of phenethylamines. It is a psychoactive drug that acts as a stimulant and hallucinogenic substance when ingested. The compound is typically used in research settings to study its effects on the central nervous system, as well as its potential therapeutic applications. Its molecular structure consists of a phenethylamine backbone with a methoxy group attached to the meta position on the phenyl ring. As a hydrochloride salt, the compound is typically in a crystalline form and is water soluble, making it easier to handle and administer in laboratory settings. Its effects on the brain and behavior have been the subject of numerous scientific studies, highlighting its potential as a substance of interest for further research.

InChI:InChI=1/C9H13NO.ClH/c1-11-9-4-2-3-8(7-9)5-6-10;/h2-4,7H,5-6,10H2,1H3;1H

Upstream product

• 19924-43-7 3-methoxyphenylacetonitrile 
• 13292-87-0 dimethyl sulfide borane 
• 2146-61-4 3-methoxyphenethyl bromide 
• 1213255-94-7 1-(2-azidoethyl)-3-methoxybenzene 

Downstream Products

• 140677-15-2 2-(1H-Indol-3-yl)-N-[2-(3-methoxy-phenyl)-ethyl]-2-oxo-acetamide 
• 109586-67-6 Methyl-6-<(2-exo/endo,3-exo)-3-<<2-(3-methoxyphenyl)ethyl>carbamoyl>bicyclo<2.2.1>hept-2-yl>hexanoat 
• 109586-67-6 Methyl-6-<(2-endo,3-exo)-3-<<2-(3-methoxyphenyl)ethyl>carbamoyl>bicyclo<2.2.1>hept-2-yl>hexanoat 
• 1233354-71-6 C₁₇H₁₈BrNO₃ 
• 1006606-19-4 1-(3-methoxyphenethyl)-3,5-bis(3-methoxyphenyl)-pyridinium triflate 
• 119503-19-4 N-<2-<3-(2-quinolinylmethoxy)phenyl>ethyl>trifluoromethanesulfonamide 
• 119481-60-6 N-<2-(3-hydroxyphenyl)ethyl>trifluoromethanesulfonamide 
• 119481-59-3 N-<2-(3-methoxyphenyl)ethyl>trifluoromethanesulfonamide 
• 104126-76-3 3-(2-(pyrrolidin-1-yl)ethyl)phenol 
• 109586-70-1 6-<(2-exo/endo,3-exo)-3-<<2-(3-Methoxyphenyl)ethyl>carbamoyl>bicyclo<2.2.1>hept-2-yl>hexansaeure 
• 140677-16-3 N-[2-(3-Methoxy-phenyl)-ethyl]-2-(5-nitro-1H-indol-3-yl)-2-oxo-acetamide 

Relevant articles and documents

Sustainable organophosphorus-catalysed Staudinger reduction

A highly efficient and sustainable catalytic Staudinger reduction for the conversion of organic azides to amines in excellent yields has been developed. The reaction displays excellent functional group tolerance to functionalities that are otherwise prone to reduction, such as sulfones, esters, amides, ketones, nitriles, alkenes, and benzyl ethers. The green nature of the reaction is exemplified by the use of PMHS, CPME, and a lack of column chromatography.

ANTIULCER BENZIMIDAZOLE DERIVATIVES

Compounds of formula I STR1 in which R 1 and R 2, which may be the same or different, are hydrogen, a C 1 to C 3 alkyl group or R 1 and R 2 together with the nitrogen to which they are attached form an optionally substituted heterocyclic ring; R 3 and R. sub.4, which may be the same or different are hydrogen, a C 1 to C. sub.3 alkyl or an optionally substituted C 3 to C 6 cycloalkyl group, or R 3 and R 4 together with the nitrogen to which they are attached form an optionally substituted heterocyclic ring; m is 0, 1 or 2; p is 0, 1 or 2; E is an alkylene group connected to or interrupted by an oxygen or a sulphur atom; J is hydrogen or a substituent group; and their pharmaceutically acceptable salts have utility as histamine H 2-receptor antagonists.